United States · FDA National Drug Code directory
Orphenadrine Citrate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 49999-046_018c5bb2-b5ea-4e62-8670-3e099c32ead9
- Product NDC
- 49999-046
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Orphenadrine Citrate
- Labeler
- Lake Erie Medical DBA Quality Care Products LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20110207 / 20261130
Source-listed ingredients
- ORPHENADRINE CITRATE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (49999-046-60) · 49999-046-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →